Comparison between Alzheimer's disease and vascular dementia: Implications for treatment

scientific article published on September 1, 2003

Comparison between Alzheimer's disease and vascular dementia: Implications for treatment is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1179/016164103101201968
P953full work available at URLhttp://www.tandfonline.com/doi/pdf/10.1179/016164103101201968
P698PubMed publication ID14503021

P2093author name stringRaj N. Kalaria
P2860cites workEffects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumQ28252389
The role of cerebral ischemia in Alzheimer's diseaseQ33950413
Dietary fat intake and the risk of incident dementia in the Rotterdam StudyQ34065622
Neuropathological assessment of the lesions of significance in vascular dementiaQ36317478
Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss.Q41644113
Hypothyroidism and cognition: preliminary evidence for a specific defect in memoryQ44108189
Absence of vascular dementia in an autopsy series from a dementia clinicQ48469403
A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.Q53322448
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
neurologyQ83042
vascular dementiaQ583908
P304page(s)661-664
P577publication date2003-09-01
P1433published inNeurological ResearchQ15765622
P1476titleComparison between Alzheimer's disease and vascular dementia: implications for treatment
Comparison between Alzheimer's disease and vascular dementia: Implications for treatment
P478volume25

Reverse relations

cites work (P2860)
Q48585087Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target
Q46404910Analysis of viral and genetic factors in South African patients with multiple sclerosis.
Q37687520Cardioprotection and anticholinesterases in patients with Alzheimer's disease: time for reappraisal
Q35688036Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain
Q36252820Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?
Q48685915Depressive symptoms and white matter changes in patients with dementia
Q83621065Early biomarkers for post-stroke cognitive impairment
Q34655353Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen
Q53314216Genetic evidence that vascular dementia is related to Alzheimer's disease: genetic association between tau polymorphism and vascular dementia in the Chinese population
Q35976397Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia
Q34028845Is apolipoprotein E4 an important risk factor for vascular dementia?
Q42472368Metabolic alterations in the hypothalamus and basal forebrain in vascular dementia
Q35841723Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias
Q48883966Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex
Q26799413Role of apolipoprotein E in neurodegenerative diseases
Q37590452Stroke and dementia
Q46547844Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study
Q64986754Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?
Q37017429Vascular dementia: pharmacological treatment approaches and perspectives
Q37299896Vascular factors and prevention of dementia.

Search more.